JAMES LAFLEUR: Open Payments
NPI 1285106096 · FAIRBANKS, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 48 payments from 14 companies in 2025. Trend: 2023 $1,442 · 2024 $2,250 · 2025 $1,535
Food & beverage: $1,435Consulting: $100
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 13 | $473 |
| AstraZeneca Pharmaceuticals LP | 4 | $227 |
| BioCryst US Sales Co., LLC | 6 | $160 |
| Amgen Inc. | 6 | $134 |
| GENZYME CORPORATION | 5 | $108 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| Resmed Corp | 1 | $100 |
| ARGENX US, INC. | 1 | $73 |
| Grifols USA, LLC | 2 | $42 |
| CSL Behring | 1 | $30 |
Products named: INSPIRE, TEZSPIRE, ORLADEYO, FASENRA, DUPIXENT, NUCALA, AIRSENSE, VYVGART.
Industry payments across AK — which companies pay providers there.
